Skip to main content

Featured

OAS Payments Are Bigger This July — Here's How Much More You'll Get

  July 21, 2026 If you or someone in your family collects Old Age Security, the deposit landing later this month is larger than the last one. Here's exactly why, and what the new numbers look like. Old Age Security payments went up 1.2% for the July-to-September 2026 quarter — the largest of the four scheduled increases so far this year. Combined with earlier adjustments, that puts OAS 2.3% higher than it was in July 2025. OAS amounts are reviewed every January, April, July, and October to track the Consumer Price Index. When the cost of living rises, the payment rises with it. When it falls, the payment simply holds steady — OAS is protected from ever decreasing. The new maximum monthly amounts Age Group April–June 2026 July–September 2026 Monthly Increase 65 to 74 $743.05 $751.97 +$8.92 75 and older $817.36 $827.17 +$9.81 Seniors 75 and up sit higher because of the permanent 10% top-up the federal government added to that age group's OAS back in July 2022. That bump applies...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment